Geographie variation in the sensitivity of recombinant antigen-based rapid tests for chronic trypanosoma cruzi infection

Jennifer R. Verani, Amy Seitz, Robert H Gilman, Carlos Lafuente, Gerson Galdos-Cardenas, Vivian Kawai, Elizabeth De Lafuente, Lisbeth Ferrufino, Natalie M. Bowman, Viviana Pinedo-Cancino, Michael Z. Levy, Francis Steurer, Charles W. Todd, Louis V. Kirchhoff, Lilia Cabrera, Manuela Verastegui, Caryn Bern

Research output: Contribution to journalArticle

Abstract

Chagas disease affects 8-11 million people throughout the Americas. Early detection is crucial for timely treatment and to prevent non-vectorial transmission. Recombinant antigen-based rapid tests had high sensitivity and specificity in laboratory evaluations, but no Peruvian specimens were included in previous studies. We evaluated Stat-Pak and Trypanosoma Detect rapid tests in specimens from Bolivia and Peru. Specimens positive by three conventional assays were confirmed positives; specimens negative by two or more assays were confirmed negatives. In Bolivian specimens, Stat-Pak and Trypanosoma Detect tests were 87.5% and 90.7% sensitive, respectively; both showed 100% specificity. Sensitivity in Peruvian specimens was much lower: 26.6-33.0% (Stat-Pak) and 54.3-55.2% (Trypanosoma Detect); both had specificities > 98%. Even in Bolivian specimens, these sensitivities are inadequate for stand-alone screening. The low sensitivity in Peru may be related to parasite strain differences. Chagas disease rapid tests should be field tested in each geographic site before widespread implementation for screening.

Original languageEnglish (US)
Pages (from-to)410-415
Number of pages6
JournalAmerican Journal of Tropical Medicine and Hygiene
Volume80
Issue number3
StatePublished - Mar 2009
Externally publishedYes

Fingerprint

Trypanosoma
Trypanosoma cruzi
Peru
Chagas Disease
Antigens
Infection
Bolivia
Parasites
Sensitivity and Specificity

ASJC Scopus subject areas

  • Parasitology
  • Infectious Diseases
  • Virology
  • Medicine(all)

Cite this

Geographie variation in the sensitivity of recombinant antigen-based rapid tests for chronic trypanosoma cruzi infection. / Verani, Jennifer R.; Seitz, Amy; Gilman, Robert H; Lafuente, Carlos; Galdos-Cardenas, Gerson; Kawai, Vivian; De Lafuente, Elizabeth; Ferrufino, Lisbeth; Bowman, Natalie M.; Pinedo-Cancino, Viviana; Levy, Michael Z.; Steurer, Francis; Todd, Charles W.; Kirchhoff, Louis V.; Cabrera, Lilia; Verastegui, Manuela; Bern, Caryn.

In: American Journal of Tropical Medicine and Hygiene, Vol. 80, No. 3, 03.2009, p. 410-415.

Research output: Contribution to journalArticle

Verani, JR, Seitz, A, Gilman, RH, Lafuente, C, Galdos-Cardenas, G, Kawai, V, De Lafuente, E, Ferrufino, L, Bowman, NM, Pinedo-Cancino, V, Levy, MZ, Steurer, F, Todd, CW, Kirchhoff, LV, Cabrera, L, Verastegui, M & Bern, C 2009, 'Geographie variation in the sensitivity of recombinant antigen-based rapid tests for chronic trypanosoma cruzi infection', American Journal of Tropical Medicine and Hygiene, vol. 80, no. 3, pp. 410-415.
Verani, Jennifer R. ; Seitz, Amy ; Gilman, Robert H ; Lafuente, Carlos ; Galdos-Cardenas, Gerson ; Kawai, Vivian ; De Lafuente, Elizabeth ; Ferrufino, Lisbeth ; Bowman, Natalie M. ; Pinedo-Cancino, Viviana ; Levy, Michael Z. ; Steurer, Francis ; Todd, Charles W. ; Kirchhoff, Louis V. ; Cabrera, Lilia ; Verastegui, Manuela ; Bern, Caryn. / Geographie variation in the sensitivity of recombinant antigen-based rapid tests for chronic trypanosoma cruzi infection. In: American Journal of Tropical Medicine and Hygiene. 2009 ; Vol. 80, No. 3. pp. 410-415.
@article{a1655f109f2143ddbeef96d28ced032d,
title = "Geographie variation in the sensitivity of recombinant antigen-based rapid tests for chronic trypanosoma cruzi infection",
abstract = "Chagas disease affects 8-11 million people throughout the Americas. Early detection is crucial for timely treatment and to prevent non-vectorial transmission. Recombinant antigen-based rapid tests had high sensitivity and specificity in laboratory evaluations, but no Peruvian specimens were included in previous studies. We evaluated Stat-Pak and Trypanosoma Detect rapid tests in specimens from Bolivia and Peru. Specimens positive by three conventional assays were confirmed positives; specimens negative by two or more assays were confirmed negatives. In Bolivian specimens, Stat-Pak and Trypanosoma Detect tests were 87.5{\%} and 90.7{\%} sensitive, respectively; both showed 100{\%} specificity. Sensitivity in Peruvian specimens was much lower: 26.6-33.0{\%} (Stat-Pak) and 54.3-55.2{\%} (Trypanosoma Detect); both had specificities > 98{\%}. Even in Bolivian specimens, these sensitivities are inadequate for stand-alone screening. The low sensitivity in Peru may be related to parasite strain differences. Chagas disease rapid tests should be field tested in each geographic site before widespread implementation for screening.",
author = "Verani, {Jennifer R.} and Amy Seitz and Gilman, {Robert H} and Carlos Lafuente and Gerson Galdos-Cardenas and Vivian Kawai and {De Lafuente}, Elizabeth and Lisbeth Ferrufino and Bowman, {Natalie M.} and Viviana Pinedo-Cancino and Levy, {Michael Z.} and Francis Steurer and Todd, {Charles W.} and Kirchhoff, {Louis V.} and Lilia Cabrera and Manuela Verastegui and Caryn Bern",
year = "2009",
month = "3",
language = "English (US)",
volume = "80",
pages = "410--415",
journal = "American Journal of Tropical Medicine and Hygiene",
issn = "0002-9637",
publisher = "American Society of Tropical Medicine and Hygiene",
number = "3",

}

TY - JOUR

T1 - Geographie variation in the sensitivity of recombinant antigen-based rapid tests for chronic trypanosoma cruzi infection

AU - Verani, Jennifer R.

AU - Seitz, Amy

AU - Gilman, Robert H

AU - Lafuente, Carlos

AU - Galdos-Cardenas, Gerson

AU - Kawai, Vivian

AU - De Lafuente, Elizabeth

AU - Ferrufino, Lisbeth

AU - Bowman, Natalie M.

AU - Pinedo-Cancino, Viviana

AU - Levy, Michael Z.

AU - Steurer, Francis

AU - Todd, Charles W.

AU - Kirchhoff, Louis V.

AU - Cabrera, Lilia

AU - Verastegui, Manuela

AU - Bern, Caryn

PY - 2009/3

Y1 - 2009/3

N2 - Chagas disease affects 8-11 million people throughout the Americas. Early detection is crucial for timely treatment and to prevent non-vectorial transmission. Recombinant antigen-based rapid tests had high sensitivity and specificity in laboratory evaluations, but no Peruvian specimens were included in previous studies. We evaluated Stat-Pak and Trypanosoma Detect rapid tests in specimens from Bolivia and Peru. Specimens positive by three conventional assays were confirmed positives; specimens negative by two or more assays were confirmed negatives. In Bolivian specimens, Stat-Pak and Trypanosoma Detect tests were 87.5% and 90.7% sensitive, respectively; both showed 100% specificity. Sensitivity in Peruvian specimens was much lower: 26.6-33.0% (Stat-Pak) and 54.3-55.2% (Trypanosoma Detect); both had specificities > 98%. Even in Bolivian specimens, these sensitivities are inadequate for stand-alone screening. The low sensitivity in Peru may be related to parasite strain differences. Chagas disease rapid tests should be field tested in each geographic site before widespread implementation for screening.

AB - Chagas disease affects 8-11 million people throughout the Americas. Early detection is crucial for timely treatment and to prevent non-vectorial transmission. Recombinant antigen-based rapid tests had high sensitivity and specificity in laboratory evaluations, but no Peruvian specimens were included in previous studies. We evaluated Stat-Pak and Trypanosoma Detect rapid tests in specimens from Bolivia and Peru. Specimens positive by three conventional assays were confirmed positives; specimens negative by two or more assays were confirmed negatives. In Bolivian specimens, Stat-Pak and Trypanosoma Detect tests were 87.5% and 90.7% sensitive, respectively; both showed 100% specificity. Sensitivity in Peruvian specimens was much lower: 26.6-33.0% (Stat-Pak) and 54.3-55.2% (Trypanosoma Detect); both had specificities > 98%. Even in Bolivian specimens, these sensitivities are inadequate for stand-alone screening. The low sensitivity in Peru may be related to parasite strain differences. Chagas disease rapid tests should be field tested in each geographic site before widespread implementation for screening.

UR - http://www.scopus.com/inward/record.url?scp=62949222879&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=62949222879&partnerID=8YFLogxK

M3 - Article

C2 - 19270291

AN - SCOPUS:62949222879

VL - 80

SP - 410

EP - 415

JO - American Journal of Tropical Medicine and Hygiene

JF - American Journal of Tropical Medicine and Hygiene

SN - 0002-9637

IS - 3

ER -